The Effects of ARA290 on the Cognitive and Neural Processing of Emotions in Healthy Volunteers

Trial Profile

The Effects of ARA290 on the Cognitive and Neural Processing of Emotions in Healthy Volunteers

Completed
Phase of Trial: Phase I/II

Latest Information Update: 18 Sep 2015

At a glance

  • Drugs Cibinetide (Primary)
  • Indications Depression
  • Focus Pharmacodynamics
  • Acronyms CONEARA
  • Most Recent Events

    • 18 Sep 2015 Results published in the European Neuropsychopharmacology.
    • 24 Feb 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Feb 2014 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top